These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 790444)

  • 21. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.
    Marcocci C; Gianchecchi D; Masini I; Golia F; Ceccarelli C; Bracci E; Fenzi GF; Pinchera A
    J Endocrinol Invest; 1990 Jun; 13(6):513-20. PubMed ID: 2258580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of radioiodine (131/125I) therapy of hyperthyroidism.
    Glanzmann C; Horst W; Magdeburg W
    Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radionuclide therapy of thyroid disease--radioactive iodine therapy].
    Kusakabe K; Maki M
    Kaku Igaku; 1993 Jul; 30(7):813-9. PubMed ID: 8377305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [131I therapy in hyperthyroidism. Results of treatment from 1960-1974].
    Heinze HG; Schenk F
    Nuklearmedizin; 1977 Feb; 16(1):1-12. PubMed ID: 846862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of a tracer dose in predicting the kinetics of therapeutic doses of 131I in thyrotoxicosis.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Sep; 52(621):719-26. PubMed ID: 476386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
    Dradi C; Riceputi G; Biagioli R; Riva P
    Minerva Med; 1979 Jan; 70(2):135-41. PubMed ID: 581903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of thyroid gland function using 125I during treatment of thyrotoxicosis with 131I].
    Livergant IuE
    Med Radiol (Mosk); 1976 Dec; 21(12):61-3. PubMed ID: 1025422
    [No Abstract]   [Full Text] [Related]  

  • 29. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.
    Canzi C; Zito F; Voltini F; Reschini E; Gerundini P
    Med Phys; 2006 Aug; 33(8):2860-7. PubMed ID: 16964862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The radiation biology of the thyroid.
    Malone JF
    Curr Top Radiat Res Q; 1975 Oct; 10(4):263-368. PubMed ID: 53121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of radioactive iodine treatment on thyroid C cells.
    Bayraktar M; Gedik O; Akalin S; Usman A; Adalar N; Telatar F
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):625-30. PubMed ID: 2253413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioprotective action of carbimazole in radioiodine therapy for thyrotoxicosis--influence of the drug on iodine kinetics.
    Connell JM; Hilditch TE; Robertson J; Coghill G; Alexander WD
    Eur J Nucl Med; 1987; 13(7):358-61. PubMed ID: 3428285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between severity of thyrotoxicosis and response to 131I therapy.
    Olsen KJ; Nielsen HE; Hansen HH
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):517-23. PubMed ID: 735855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
    Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
    Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient hypothyroidism following radioiodine therapy for thyrotoxicosis.
    Connell JM; Hilditch TE; McCruden DC; Alexander WD
    Br J Radiol; 1983 May; 56(665):309-13. PubMed ID: 6850213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990-2002).
    Nykamp SG; Dykes NL; Zarfoss MK; Scarlett JM
    J Am Vet Med Assoc; 2005 May; 226(10):1671-5. PubMed ID: 15906566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of thyrotoxicosis--the current position. 3. Radioiodine therapy. Special considerations.
    Greig WR
    Curr Med Res Opin; 1973; 1(6):331-41. PubMed ID: 4589405
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D; Voth E; Schicha H
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.